Project: 2007

Sector: HEALTH

B. Model: B2B

Stage: PRE-SEED

Neurosciences brand to train brain for higher performance

Boosts athletes’ performance by reducing anxiety and improving emotional control via neuro-feedback

Uses app and neuro-feedback to read brain waves fed into simulator

Problem

Personal performance enhancement (psychological + physical) is a top priority for top professional athletes.

Opportunity

Global market.
Cognitive assessment and training growing 25% / year (9 B$ US 2023).

Value Proposition

Cognitive performance training.

Control and reduce anxiety for better performance – sports + corporate.

Business Overview

Neurosciences brand to train brain for higher performance

Boosts athletes’ performance by reducing anxiety and improving emotional control via neuro-feedback

Uses app and neuro-feedback to read brain waves fed into simulator

Team

Pedro Pestana - CEO

Background in biomedical engineering

Hugo Ferreira - CMO

Background in medicine and physics

Ana Monteiro - Psychologist

Background in neuro feedback

Media

Project Highlights

Awarded Best New Brand at…

Press coverage from notable publications including…

Angel investors include…

UNION Team Assessment

Neurosciences brand to train brain for higher performance

Boosts athletes’ performance by reducing anxiety and improving emotional control via neuro-feedback

Uses app and neuro-feedback to read brain waves fed into simulator

UNION Data Room

Venture Builders Program

Program Fase
70%

Company

Name: NEROES

Incorporation: NO

Location: NA

Stage: Pre Seed

Funding: Personal 

Cap Table: Founders

Fundraising Description

Ask: 150K€

Type: Equity

Participation: 15%

Valuation: 1000K€

Terms

The Form C is a document the company must file with the Securities and Exchange Commission (“SEC”) which includes basic information about the company and its offering and is a condition to making a Reg CF offering available to investors. It is important to note that the SEC does not review the Form C, and therefore is not recommending and/or approving any of the securities being offered.